Related Experiment Video
Updated: Jun 25, 2026
07:50
Assay Development for High-Throughput Drug Screening Against Mycobacteria
Published on: October 25, 2024
Ceftaroline: a cephalosporin with expanded Gram-positive activity
Zeina A Kanafani1, G Ralph Corey
1Division of Infectious Diseases, American University of Beirut Medical Center, Cairo Street, PO Box 11-0236/11D, Riad El Solh 1107 2020, Beirut, Lebanon. zk10@aub.edu.lb
Future Microbiology
|February 12, 2009
Summary
Ceftaroline is a new antibiotic effective against resistant Gram-positive infections like MRSA. Clinical trials show it is well-tolerated for skin infections, with ongoing studies for pneumonia.
Area of Science:
- Infectious Diseases
- Pharmacology
- Microbiology
Background:
- Resistant Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA), present a significant health risk in healthcare and community settings.
- There is a critical need for novel antibiotics with proven clinical efficacy and a good safety profile to combat these resistant infections.
Purpose of the Study:
- To evaluate the efficacy and safety of ceftaroline, a novel cephalosporin antibiotic, for treating infections caused by resistant Gram-positive pathogens.
- To assess ceftaroline's activity against a spectrum of resistant bacteria, including MRSA, vancomycin-intermediate S. aureus, vancomycin-resistant S. aureus, and multidrug-resistant Streptococcus pneumoniae.
Main Methods:
- Phase II and III clinical studies were conducted to compare ceftaroline with standard therapies.
- Studies assessed clinical outcomes, including efficacy and tolerability, in patients with complicated skin and skin-structure infections.
- Ongoing trials are investigating ceftaroline for the treatment of community-acquired pneumonia.
Main Results:
- Phase II and III studies demonstrated that ceftaroline is an effective treatment for complicated skin and skin-structure infections.
- Ceftaroline was found to be well-tolerated in patients receiving treatment for these infections.
- The antibiotic exhibits expanded activity against key Gram-positive resistant pathogens while maintaining efficacy against Gram-negative organisms.
Conclusions:
- Ceftaroline represents a promising therapeutic option for infections caused by challenging Gram-positive resistant bacteria.
- Its favorable efficacy and safety profile in skin infections supports its role in combating antibiotic resistance.
- Further research, including ongoing trials for community-acquired pneumonia, will continue to define ceftaroline's clinical utility.
Related Concept Videos
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:28Inhibitors of Bacterial DNA Synthesis
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
01:30Bacterial Phylum Actinobacteria
Coryneform bacteria are gram-positive, aerobic, nonmotile rods that exhibit irregular, club-shaped, or V-shaped arrangements. Their V-shape results from snapping division, where the inner cell wall layer forms the cross-wall, while the outer layer remains intact until it ruptures on one side, causing the daughter cells to bend away.The primary genera are Corynebacterium and Arthrobacter. Corynebacterium includes diverse species, ranging from saprophytes to pathogens like Corynebacterium...
01:22Bacterial Cell Wall
The bacterial cell wall is an essential structural component that encases the plasma membrane, preserving cellular integrity, determining shape, and protecting against osmotic stress. This rigid yet flexible structure primarily comprises peptidoglycan, a polymer that forms a mesh-like matrix conferring mechanical strength and flexibility.Peptidoglycan Composition and StructurePeptidoglycan, the core of the bacterial cell wall, comprises alternating units of N-acetylglucosamine (NAG) and...